Animal models of human anthrax: The Quest for the Holy Grail

Molecular Aspects of Medicine

Volumn 30, Issue 6, 2009, Pages 467-480

  Goossens, Pierre L ^a  

^a CNRS   (France)

Author keywords

Animal model; Anthrax; Bacillus anthracis; Bacterial infection; Guinea pig; Lung; Mediastinal lymph node; Mouse; Non human primate; Pleura; Rabbit; Rat; Toxin

Indexed keywords

ANIMAL MODEL; ANTHRAX; GUINEA PIG; HOST PATHOGEN INTERACTION; HUMAN; INFECTION; LYMPHATIC DRAINAGE; MEDIASTINUM LYMPH NODE; NONHUMAN; PLEURA; PRIMATE; RABBIT; REVIEW; TOXEMIA;

ANIMALS; ANTHRAX; BACILLUS ANTHRACIS; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INHALATION EXPOSURE; SPORES, BACTERIAL;

ANIMALIA; BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); CAVIA; ORYCTOLAGUS CUNICULUS; PRIMATES; RATTUS;

EID: 70350728674     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2009.07.005     Document Type: Review

References (117)

1. Abramova F.A., Grinberg L.M., Yampolskaya O.V., and Walker D.H. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc. Natl. Acad. Sci. USA 90 (1993) 2291-2294
2. Albrecht M.T., Li H., Williamson E.D., LeButt C.S., Flick-Smith H.C., Quinn C.P., Westra H., Galloway D., Mateczun A., Goldman S., Groen H., and Baillie L.W. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax. Infect. Immun. 75 (2007) 5425-5433
3. Anaraki S., Addiman S., Nixon G., Krahe D., Ghosh R., Brooks T., Lloyd G., Spencer R., Walsh A., McCloskey B., and Lightfoot N. Investigations and control measures following a case of inhalation anthrax in east London in a drum maker and drummer, October 2008. Euro Surveill. 13 (2008)
4. Baluk P., Fuxe J., Hashizume H., Romano T., Lashnits E., Butz S., Vestweber D., Corada M., Molendini C., Dejana E., and McDonald D.M. Functionally specialized junctions between endothelial cells of lymphatic vessels. J. Exp. Med. 204 (2007) 2349-2362
5. Beall F.A., Taylor M.J., and Thorne C.B. Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis. J. Bacteriol. 83 (1962) 1274-1280
6. Beatty M.E., Ashford D.A., Griffin P.M., Tauxe R.V., and Sobel J. Gastrointestinal anthrax: review of the literature. Arch. Intern. Med. 163 (2003) 2527-2531
7. Berdjis C.C., Gleiser C.A., Hartmen H.A., Kuehne R.W., and Gochenour W.S. Pathogenesis of respiratory anthrax in Macaca mulatta. Br. J. Exp. Pathol. 43 (1962) 515-524
8. Berdjis C.C., Gleiser C.A., and Hartman H.A. Experimental parenteral anthrax in Macaca mulatta. Br. J. Exp. Pathol. 44 (1963) 101-115
9. Bolcome III R.E., Sullivan S.E., Zeller R., Barker A.P., Collier R.J., and Chan J. Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature. Proc. Natl. Acad. Sci. USA 105 (2008) 2439-2444
10. Boyanovsky B.B., and Webb N.R. Biology of secretory phospholipase A2. Cardiovasc. Drugs Ther. 23 (2009) 61-72
11. Brossier F., Levy M., and Mock M. Anthrax spores make an essential contribution to vaccine efficacy. Infect. Immun. 70 (2002) 661-664
12. Byrd L.G., and Prince G.A. Animal models of respiratory syncytial virus infection. Clin. Infect. Dis. 25 (1997) 1363-1368
13. Cambre R.C., Wilson H.L., Spraker T.R., and Favara B.E. Fatal airsacculitis and pneumonia, with abortion, in an orangutan. J. Am. Vet. Med. Assoc. 177 (1980) 822-824
14. Capitanio J.P., and Emborg M.E. Contributions of non-human primates to neuroscience research. Lancet 371 (2008) 1126-1135
15. Cerquetti M.C., Sordelli D.O., Ortegon R.A., and Bellanti J.A. Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement. Infect. Immun. 41 (1983) 1071-1076
16. Cerquetti M.C., Sordelli D.O., Bellanti J.A., and Hooke A.M. Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds. Infect. Immun. 52 (1986) 853-857
17. Cleret A., Quesnel-Hellmann A., Mathieu J., Vidal D., and Tournier J.N. Resident CD11c+ lung cells are impaired by anthrax toxins after spore infection. J. Infect. Dis. 194 (2006) 86-94
18. Cleret A., Quesnel-Hellmann A., Vallon-Eberhard A., Verrier B., Jung S., Vidal D., Mathieu J., and Tournier J.N. Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J. Immunol. 178 (2007) 7994-8001
19. Cote C.K., Rea K.M., Norris S.L., van Rooijen N., and Welkos S.L. The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb. Pathog. 37 (2004) 169-175
20. Cowan G.J., Atkins H.S., Johnson L.K., Titball R.W., and Mitchell T.J. Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis. Vaccine 25 (2007) 7197-7205
21. Cromartie W.J., Bloom W.L., and Watson D.W. Studies on infection with Bacillus anthracis. I. A histopathological study of skin lesions produced by B. anthracis in susceptible and resistant animal species. J. Infect. Dis. 80 (1947) 1-13
22. Darby C. Interactions with microbial pathogens. WormBook (2005) 1-15
23. D'Erchia A.M., Gissi C., Pesole G., Saccone C., and Arnason U. The guinea-pig is not a rodent. Nature 381 (1996) 597-600
24. Dixon T.C., Meselson M., Guillemin J., and Hanna P.C. Anthrax. N. Engl. J. Med. 341 (1999) 815-826
25. Drysdale M., Heninger S., Hutt J., Chen Y., Lyons C.R., and Koehler T.M. Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. EMBO J (2004)
26. Duong S., Chiaraviglio L., and Kirby J.E. Histopathology in a murine model of anthrax. Int. J. Exp. Pathol. 87 (2006) 131-137
27. Eerola L.I., Surrel F., Nevalainen T.J., Gelb M.H., Lambeau G., and Laine V.J. Analysis of expression of secreted phospholipases A2 in mouse tissues at protein and mRNA levels. BBAa 1761 (2006) 745-756
28. Ezzell J.W., Ivins B.E., and Leppla S.H. Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin. Infect. Immun. 45 (1984) 761-767
29. Fedhila S., Daou N., Lereclus D., and Nielsen-LeRoux C. Identification of Bacillus cereus internalin and other candidate virulence genes specifically induced during oral infection in insects. Mol. Microbiol. 62 (2006) 339-355
30. Firoved A.M., Miller G.F., Moayeri M., Kakkar R., Shen Y., Wiggins J.F., McNally E.M., Tang W.J., and Leppla S.H. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am. J. Pathol. 167 (2005) 1309-1320
31. Friedlander, A.M., 1997. Chapter 22: Anthrax. In: Russ Zajtchuk (Ed.), Medical Aspects of Chemical and Biological Warfare. Office of the Surgeon General, Borden Institute, Walter Reed Army Medical Center, Washington, DC, pp. 467-478.
32. Friedlander A.M. Anthrax: clinical features, pathogenesis, and potential biological warfare threat. Curr. Clin. Top. Infect. Dis. 20 (2000) 335-349
33. Friedlander A.M. Diagnosis and treatment of cutaneous anthrax. JAMA 288 (2002) 43-44 author reply 44
34. Friedlander A.M., Welkos S.L., Pitt M.L., Ezzell J.W., Worsham P.L., Rose K.J., Ivins B.E., Lowe J.R., Howe G.B., Mikesell P., et al. Postexposure prophylaxis against experimental inhalation anthrax. J. Infect. Dis. 167 (1993) 1239-1243
35. Fritz D.L., Jaax N.K., Lawrence W.B., Davis K.J., Pitt M.L., Ezzell J.W., and Friedlander A.M. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab. Invest. 73 (1995) 691-702
36. Gervais F., Stevenson M., and Skamene E. Genetic control of resistance to Listeria monocytogenes: regulation of leukocyte inflammatory responses by the Hc locus. J. Immunol. 132 (1984) 2078-2083
37. Gleiser C.A. Pathology of anthrax infection in animal hosts. Fed. Proc. 26 (1967) 1518-1521
38. Gleiser C.A., Berdjis C.C., Hartman H.A., and Gochenour W.S. Pathology of experimental respiratory anthrax in Macaca mulatta. Br. J. Exp. Pathol. 44 (1963) 416-426
39. Gleiser C.A., Gochenour Jr. W.S., and Ward M.K. Pulmonary lesions in dogs and pigs exposed to a cloud of anthrax spores. J. Comp. Pathol. 78 (1968) 445-448
40. Glomski I.J., Corre J.P., Mock M., and Goossens P.L. Non-capsulated toxinogenic Bacillus anthracis present a specific growth and dissemination pattern in naive and PA-immune mice. Infect. Immun. 75 (2007) 4754-4761
41. Glomski I.J., Corre J.P., Mock M., and Goossens P.L. Cutting edge: IFN-{gamma}-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis. J. Immunol. 178 (2007) 2646-2650
42. Glomski I.J., Piris-Gimenez A., Huerre M., Mock M., and Goossens P.L. Primary involvement of pharynx and Peyer's patch in inhalational and intestinal anthrax. PLoS Pathogens 3 (2007) e76
43. Glomski I.J., Dumetz F., Jouvion G., Huerre M.R., Mock M., and Goossens P.L. Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specific organ targeting. Microbes Infect. 10 (2008) 1398-1404
44. Griffiths M.M., Encinas J.A., Remmers E.F., Kuchroo V.K., and Wilder R.L. Mapping autoimmunity genes. Curr. Opin. Immunol. 11 (1999) 689-700
45. Guidi-Rontani C., Weber-Levy M., Labruyere E., and Mock M. Germination of Bacillus anthracis spores within alveolar macrophages. Mol. Microbiol. 31 (1999) 9-17
46. Hahn U.K., Alex M., Czerny C.P., Bohm R., and Beyer W. Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination. Int. J. Med. Microbiol. 294 (2004) 35-44
47. Harvill E.T., Lee G., Grippe V.K., and Merkel T.J. Complement depletion renders C57BL/6 mice sensitive to the Bacillus anthracis Sterne strain. Infect. Immun. 73 (2005) 4420-4422
48. Hau J. Animal models for human diseases. In: Conn P.M. (Ed). Sourcebook of Models for Biomedical Research (2008), Humana Press Inc., Towota, NJ 3-8
49. Heffernan B.J., Thomason B., Herring-Palmer A., and Hanna P. Bacillus anthracis anthrolysin O and three phospholipases C are functionally redundant in a murine model of inhalation anthrax. FEMS Microbiol. Lett. 271 (2007) 98-105
50. Henderson D.W., Peacock S., and Belton F.C. Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. J. Hyg. 54 (1956) 28-36
51. Hewitt G., MacLarnon A., and Jones K.E. The functions of laryngeal air sacs in primates: a new hypothesis. Folia primatologica; Int. J. Primatol. 73 (2002) 70-94
52. Hoffmaster A.R., Ravel J., Rasko D.A., Chapman G.D., Chute M.D., Marston C.K., De B.K., Sacchi C.T., Fitzgerald C., Mayer L.W., Maiden M.C., Priest F.G., Barker M., Jiang L., Cer R.Z., Rilstone J., Peterson S.N., Weyant R.S., Galloway D.R., Read T.D., Popovic T., and Fraser C.M. Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proc. Natl. Acad. Sci. USA 101 (2004) 8449-8454
53. Holty J.E., Bravata D.M., Liu H., Olshen R.A., McDonald K.M., and Owens D.K. Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann. Intern. Med. 144 (2006) 270-280
54. Hughes R., May A.J., and Widdicombe J.G. The role of the lymphatic system in the pathogenesis of anthrax. Br. J. Exp. Pathol. 37 (1956) 343-349
55. Ivins B.E., Pitt M.L., Fellows P.F., Farchaus J.W., Benner G.E., Waag D.M., Little S.F., Anderson Jr. G.W., Gibbs P.H., and Friedlander A.M. Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. Vaccine 16 (1998) 1141-1148
56. Jernigan J.A., Stephens D.S., Ashford D.A., Omenaca C., Topiel M.S., Galbraith M., Tapper M., Fisk T.L., Zaki S., Popovic T., Meyer R.F., Quinn C.P., Harper S.A., Fridkin S.K., Sejvar J.J., Shepard C.W., McConnell M., Guarner J., Shieh W.J., Malecki J.M., Gerberding J.L., Hughes J.M., and Perkins B.A. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis. 7 (2001) 933-944
57. Jones Jr. W.I., Klein F., Walker J.S., Mahlandt B.G., Dobbs J.P., and Lincoln R.E. In vivo growth and distribution of anthrax bacilli in resistant, susceptible, and immunized hosts. J. Bacteriol. 94 (1967) 600-608
58. Kim C., Gajendran N., Mittrucker H.W., Weiwad M., Song Y.H., Hurwitz R., Wilmanns M., Fischer G., and Kaufmann S.H. Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc. Natl. Acad. Sci. USA 102 (2005) 4830-4835
59. Kirschvink N., and Reinhold P. Use of alternative animals as asthma models. Curr. Drug Targets 9 (2008) 470-484
60. Klee S.R., Ozel M., Appel B., Boesch C., Ellerbrok H., Jacob D., Holland G., Leendertz F.H., Pauli G., Grunow R., and Nattermann H. Characterization of Bacillus anthracis-like bacteria isolated from wild great apes from Cote d'Ivoire and Cameroon. J. Bacteriol. 188 (2006) 5333-5344
61. Klein F., Haines B.W., Mahlandt B.G., Dearmon Jr. I.A., and Lincoln R.E. Dual nature of resistance mechanisms as revealed by studies of anthrax septicemia. J. Bacteriol. 85 (1963) 1032-1038
62. Koduri R.S., Gronroos J.O., Laine V.J., Le Calvez C., Lambeau G., Nevalainen T.J., and Gelb M.H. Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2). J. Biol. Chem. 277 (2002) 5849-5857
63. Lambeau G., and Gelb M.H. Biochemistry and physiology of mammalian secreted phospholipases A2. Annual Review of Biochemistry 77 (2008) 495-520
64. Lanska D.J. Anthrax meningoencephalitis. Neurology 59 (2002) 327-334
65. Lawrence W.S., Hardcastle J.M., Brining D.L., Weaver L.E., Ponce C., Whorton E.B., and Peterson J.W. The physiologic responses of Dutch belted rabbits infected with inhalational anthrax. Comp. Med. 59 (2009) 257-265
66. Lawson B., Garriga R., and Galdikas B.M. Airsacculitis in fourteen juvenile southern Bornean orangutans (Pongo pygmaeus wurmbii). J. Med. Primatol. 35 (2006) 149-154
67. Leppla S.H. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. USA 79 (1982) 3162-3166
68. Lever M.S., Stagg A.J., Nelson M., Pearce P., Stevens D.J., Scott E.A., Simpson A.J., and Fulop M.J. Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus). Int. J. Exp. Pathol. 89 (2008) 171-179
69. Levraud J.P., Disson O., Kissa K., Bonne I., Cossart P., Herbomel P., and Lecuit M. Real-time observation of Listeria-phagocyte interactions in the living zebrafish larva. Infect. Immun. (2009)
70. Lincoln R.E., Hodges D.R., Klein F., Mahlandt B.G., Jones Jr. W.I., Haines B.W., Rhian M.A., and Walker J.S. Role of the lymphatics in the pathogenesis of anthrax. J. Infect. Dis. 115 (1965) 481-494
71. Lisanby M.W., Swiecki M.K., Dizon B.L., Pflughoeft K.J., Koehler T.M., and Kearney J.F. Cathelicidin administration protects mice from Bacillus anthracis spore challenge. J. Immunol. 181 (2008) 4989-5000
72. Little S.F., and Knudson G.B. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Infect. Immun. 52 (1986) 509-512
73. Lovchik, J., Drysdale, M., Koehler, T.M., Hutt, J., Lyons, C.R., 2007. Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax. In: Bacillus - ACT 2007 International Conference, Oslo, vol. P51, p. 72.
74. Loving C.L., Kennett M., Lee G.M., Grippe V.K., and Merkel T.J. Murine aerosol challenge model of anthrax. Infect. Immun. 75 (2007) 2689-2698
75. Loving C.L., Khurana T., Osorio M., Lee G.M., Kelly V.K., Stibitz S., and Merkel T.J. Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model. Infect. Immun. 77 (2009) 255-265
76. Martin J.S., and Renshaw S.A. Using in vivo zebrafish models to understand the biochemical basis of neutrophilic respiratory disease. Biochem. Soc. Trans. 37 (2009) 830-837
77. MMWR. Cutaneous anthrax associated with drum making using goat hides from West Africa-Connecticut, 2007. MMWR Morb. Mortal Wkly. Rep. 57 (2008) 628-631
78. Moayeri M., Haines D., Young H.A., and Leppla S.H. Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J. Clin. Invest. 112 (2003) 670-682
79. Mock M., and Fouet A. Anthrax. Annu. Rev. Microbiol. 55 (2001) 647-671
80. Mohamadzadeh M., Duong T., Sandwick S.J., Hoover T., and Klaenhammer T.R. Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc. Natl. Acad. Sci. USA 106 (2009) 4331-4336
81. Molin F.D., Fasanella A., Simonato M., Garofolo G., Montecucco C., and Tonello F. Ratio of lethal and edema factors in rabbit systemic anthrax. Toxicon 52 (2008) 824-828
82. Morgan K.T., and Monticello T.M. Airflow, gas deposition, and lesion distribution in the nasal passages. Environ. Health Perspect. 85 (1990) 209-218
83. Okiemy G., Foucault C., Avisse C., Hidden G., and Riquet M. Lymphatic drainage of the diaphragmatic pleura to the peritracheobronchial lymph nodes. Surg. Radiol. Anat. 25 (2003) 32-35
84. Padilla-Carlin D.J., McMurray D.N., and Hickey A.J. The guinea pig as a model of infectious diseases. Comp. Med. 58 (2008) 324-340
85. Piris Giménez, A., Corre, J.P., Khun, H., Huerre, M., Glomski, I.J., Mock, M., Goossens, P.L., 2007. Kinetics of germination and dissemination of a septicemic non-toxinogenic Bacillus anthracis strain during a cutaneous infcetion in mice. In: Bacillus - ACT 2007 International Conference, Oslo, p. 41.
86. Piris-Gimenez, A., Corre, J.P., Jouvion, G., Candela, T., Khun, H., Goossens, P.L., 2009. Encapsulated B. anthracis interacts closely with liver endothelium. J. Infect. Dis., in press.
87. Ribot W.J., Powell B.S., Ivins B.E., Little S.F., Johnson W.M., Hoover T.A., Norris S.L., Adamovicz J.J., Friedlander A.M., and Andrews G.P. Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits. Vaccine 24 (2006) 3469-3476
88. Ricciardolo F.L., Nijkamp F., De Rose V., and Folkerts G. The guinea pig as an animal model for asthma. Curr. Drug Targets 9 (2008) 452-465
89. Richmond I., Pritchard G.E., Ashcroft T., Avery A., Corris P.A., and Walters E.H. Bronchus associated lymphoid tissue (BALT) in human lung: its distribution in smokers and non-smokers. Thorax 48 (1993) 1130-1134
90. Ross J.M. The pathogenesis of anthrax following the administration of spores by the respiratory route. J. Pathol. Bacteriol. 73 (1957) 485-494
91. Russell B.H., Liu Q., Jenkins S.A., Tuvim M.J., Dickey B.F., and Xu Y. In vivo demonstration and quantification of intracellular Bacillus anthracis in lung epithelial cells. Infect. Immun. 76 (2008) 3975-3983
92. Russell B.H., Vasan R., Keene D.R., Koehler T.M., and Xu Y. Potential dissemination of Bacillus anthracis utilizing human lung epithelial cells. Cell. Microbiol. 10 (2008) 945-957
93. Sahn S.A. The pathophysiology of pleural effusions. Ann. Rev. Med. 41 (1990) 7-13
94. Saile E., and Koehler T.M. Bacillus anthracis multiplication, persistence, and genetic exchange in the rhizosphere of grass plants. Appl. Environ. Microbiol. 72 (2006) 3168-3174
95. Sane A.C., Mendenhall T., and Bass D.A. Secretory phospholipase A2 activity is elevated in bronchoalveolar lavage fluid after ovalbumin sensitization of guinea pigs. J. Leukocyte Biol. 60 (1996) 704-709
96. Sanz P., Teel L.D., Alem F., Carvalho H.M., Darnell S.C., and O'Brien A.D. Detection of Bacillus anthracis spore germination in vivo by bioluminescence imaging. Infect. Immun. 76 (2008) 1036-1047
97. Sharma A., Fidias P., Hayman L.A., Loomis S.L., Taber K.H., and Aquino S.L. Patterns of lymphadenopathy in thoracic malignancies. Radiographics 24 (2004) 419-434
98. Shlyakhov E.N., and Rubinstein E. Human live anthrax vaccine in the former USSR. Vaccine 12 (1994) 727-730
99. Shoop W.L., Xiong Y., Wiltsie J., Woods A., Guo J., Pivnichny J.V., Felcetto T., Michael B.F., Bansal A., Cummings R.T., Cunningham B.R., Friedlander A.M., Douglas C.M., Patel S.B., Wisniewski D., Scapin G., Salowe S.P., Zaller D.M., Chapman K.T., Scolnick E.M., Schmatz D.M., Bartizal K., MacCoss M., and Hermes J.D. Anthrax lethal factor inhibition. Proc. Natl. Acad. Sci. USA 102 (2005) 7958-7963
100. Sterne M. The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis. Onderstepoort. J. Vet. Sci. Animal Indust. 13 (1939) 307-312
101. Sternberg E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nature Rev. 6 (2006) 318-328
102. Toews G.B., and Vial W.C. The role of C5 in polymorphonuclear leukocyte recruitment in response to Streptococcus pneumoniae. Am. Rev. Resp. Dis. 129 (1984) 82-86
103. Touqui L., and Alaoui-El-Azher M. Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr. Mol. Med. 1 (2001) 739-754
104. Tournier J.N., Cleret A., and Quesnel-Hellmann A. What is the relevance of lung epithelial cells during the dissemination of spores in inhalational anthrax?. Infect. Immun. 77 (2009) 565 author reply 565-566
105. Trapnell D.H. The peripheral lymphatics of the lung. Brit. J. Radiol. 36 (1963) 660-672
106. Tree J.A., Elmore M.J., Javed S., Williams A., and Marsh P.D. Development of a guinea pig immune response-related microarray and its use to define the host response following Mycobacterium bovis BCG vaccination. Infect. Immun. 74 (2006) 1436-1441
107. Vasconcelos D., Barnewall R., Babin M., Hunt R., Estep J., Nielsen C., Carnes R., and Carney J. Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis). Lab. Invest. 83 (2003) 1201-1209
108. Wang W., Mulakala C., Ward S.C., Jung G., Luong H., Pham D., Waring A.J., Kaznessis Y., Lu W., Bradley K.A., and Lehrer R.I. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J. Biol. Chem. 281 (2006) 32755-32764
109. Webster Marketon J.I., and Glaser R. Stress hormones and immune function. Cell. Immunol. 252 (2008) 16-26
110. Weinrauch Y., Elsbach P., Madsen L.M., Foreman A., and Weiss J. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J. Clin. Invest. 97 (1996) 250-257
111. Welkos S.L. Plasmid-associated virulence factors of non-toxigenic (pX01-) Bacillus anthracis. Microb. Pathog. 10 (1991) 183-198
112. Welkos S.L., and Friedlander A.M. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. Microb. Pathog. 5 (1988) 127-139
113. Welkos S.L., Keener T.J., and Gibbs P.H. Differences in susceptibility of inbred mice to Bacillus anthracis. Infect. Immun. 51 (1986) 795-800
114. Wu Y., Singer M., Thouron F., Alaoui-El-Azher M., and Touqui L. Effect of surfactant on pulmonary expression of type IIA PLA(2) in an animal model of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 282 (2002) L743-750
115. Zaucha G.M., Pitt L.M., Estep J., Ivins B.E., and Friedlander A.M. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch. Pathol. Lab. Med. 122 (1998) 982-992
116. Ziemssen T., and Kern S. Psychoneuroimmunology-cross-talk between the immune and nervous systems. Journal of Neurology 254 Suppl. 2 (2007) II8-II11
117. Zocchi L. Physiology and pathophysiology of pleural fluid turnover. Eur. Respir. J. 20 (2002) 1545-1558